Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer (CRITICAL)

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborators:

Prostate Institute of America

Community Memorial Hospital

HemaCare Corporation

Information provided by (Responsible Party):

Bostwick Laboratories

ClinicalTrials.gov Identifier:

NCT00753220

First received: September 12, 2008

Last updated: September 20, 2011

Last verified: September 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2011
Estimated Primary Completion Date:	December 2011 (Final data collection date for primary outcome measure)